NCT07377188 Pregnancy and Inflammatory Bowel Disease
| NCT ID | NCT07377188 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire, Amiens |
| Condition | IBD |
| Study Type | OBSERVATIONAL |
| Enrollment | 945 participants |
| Start Date | 2020-09-18 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 945 participants in total. It began in 2020-09-18 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Inflammatory Bowel disease, including Crohn's disease and Ulcerative Colitis, are chronic diseases. Diagnosis is most often done in women of childbearing age. IBD can have and increase the risk of intrauterine growth retardation, preterm birth… Conversely, pregnancy can have an impact on IBD activity during pregnancy. Moreover, IBD course can be influence in post-partum. The investigators will explore IBD course on 945 patients from the EPIMAD register. The investigators will cross the data on the IBD with data on pregnancy, postpartum but also breastfeeding. The principal aim of this study is to assess the number of flares during pregnancy.
Eligibility Criteria
Inclusion Criteria: * women between 18 and 50 years old * MICI diagnosed between 1988 and 2018 * included in EPIMAD registry * living in Somme * having had at least one pregnancy Exclusion Criteria: * women who has not had pregnancy * not included in EPIMAD register
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07377188 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying IBD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07377188 currently recruiting?
Yes, NCT07377188 is actively recruiting participants. Contact the research team at foulon.arthur@chu-amiens.fr for enrollment information.
Where is the NCT07377188 trial being conducted?
This trial is being conducted at Amiens, France.
Who is sponsoring the NCT07377188 clinical trial?
NCT07377188 is sponsored by Centre Hospitalier Universitaire, Amiens. The trial plans to enroll 945 participants.